Association between mitochondrial haplogroups and ranibizumab response in neovascular age-related macular degeneration

被引：0
|
作者：
Ascaso, Francisco [1 ,2 ]
Esteban, Olivia [1 ,2 ]
Montoya, Julio [2 ,3 ]
Montes, Paula [1 ]
Mateo, Javier [1 ,2 ]
Lara, Javier [1 ]
Ruiz-Pesini, Eduardo [2 ,3 ]
机构：
[1] Hosp Clin Univ Lozano Blesa, Dept Ophthalmol, Zaragoza, Spain
[2] Inst Aragones Ciencias Salud, Zaragoza, Spain
[3] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza, Spain
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2954
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Therapeutic effects of ranibizumab in neovascular age-related macular degeneration
    Ciulla, Thomas A.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (05) : 679 - 693
  • [22] Ranibizumab versus verteporfin for neovascular age-related macular degeneration
    Brown, David M.
    Kaiser, Peter K.
    Michels, Mark
    Soubrane, Gisele
    Heier, Jeffrey S.
    Kim, Robert Y.
    Sy, Judy P.
    Schneider, Susan
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1432 - 1444
  • [23] Genetic Association with Response to Intravitreal Ranibizumab for Neovascular Age-Related Macular Degeneration in the Han Chinese Population
    Yuan, Dongqing
    Yuan, Donglan
    Liu, Xiaoyi
    Yuan, Songtao
    Xie, Ping
    Liu, Qinghuai
    OPHTHALMOLOGICA, 2013, 230 (04) : 227 - 232
  • [24] Mitochondrial DNA Haplogroups Associated with Age-Related Macular Degeneration
    Udar, Nitin
    Atilano, Shari R.
    Memarzadeh, Masood
    Boyer, David S.
    Chwa, Marilyn
    Lu, Stephanie
    Maguen, Barak
    Langberg, Jonathan
    Coskun, Pinar
    Wallace, Douglas C.
    Nesburn, Anthony B.
    Khatibi, Nikan
    Hertzog, Dieter
    Le, Khoi
    Hwang, Daniel
    Kenney, M. Cristina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (06) : 2966 - 2974
  • [25] Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
    Chan, Clement K.
    Beaulieu, Wesley T.
    Lujan, Brandon J.
    Lalezary, Maziar
    Lent-Schochet, Daniella
    Lo, Therlinder
    Yiu, Glenn
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2023, 12 (09):
  • [26] Predicting Non-response to Ranibizumab in Patients with Neovascular Age-related Macular Degeneration
    van Asten, Freekje
    Rovers, Maroeska M.
    Lechanteur, Yara T. E.
    Smailhodzic, Dzenita
    Muether, Philipp S.
    Chen, John
    den Hollander, Anneke I.
    Fauser, Sascha
    Hoyng, Carel B.
    van der Wilt, Gert Jan
    Klevering, B. Jeroen
    OPHTHALMIC EPIDEMIOLOGY, 2014, 21 (06) : 347 - 355
  • [27] A Baseline Score to Predict Response to Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration
    Diack, Cheikh
    Schwab, Dietmar
    Cosson, Valerie
    Buchheit, Vincent
    Mazer, Norman
    Frey, Nicolas
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2021, 10 (06):
  • [28] Predicting Non-response to Ranibizumab in Patients with Neovascular Age-related Macular Degeneration
    van Asten, Freekje
    Rovers, Maroeska
    Lechanteur, Yara
    Smailhodzic, Dzenita
    Muether, Philipp
    Den Hollander, Anneke
    Fauser, Sascha
    Hoyng, Carel
    van der Wilt, Gert Jan
    Klevering, B. Jeroen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [29] VEGF Gene Polymorphism and Response to Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration
    dos Reis Veloso, Carlos Eduardo
    Frota de Almeida, Luciana Negrao
    Maria Recchia, Franco
    Pelayes, David
    Nehemy, Marcio Bittar
    OPHTHALMIC RESEARCH, 2014, 51 (01) : 1 - 8
  • [30] Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration
    Timothy Y. Y. Lai
    Wai-Man Chan
    David T. Liu
    Dennis S. Lam
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2007, 245 : 1877 - 1880
12345